Systemic inflammation, indicated by NLR, contributes to HPV persistence and CIN progression. »
01/24/25

Treatment with [225Ac]Ac-macropa-nimotuzumab-PEG6-DM1 potential therapy. »
03/18/25

Low GCNT2 levels associated with advanced tumor stage and grade. »
02/20/25

No evidence of association of HLA-A*02:01 with organ-specific irAEs. »
03/28/25

Correlation of PD-1 and LAG-3 expression between tumor-associated and peripheral immune cells. »
03/27/25

RNA sequencing data revealed significant insights into RNA profiles of sEVs. »
03/27/25

Immune recruitment and viral defense gene networks strongly associated with pCR. »
03/26/25

Significant suppression of cell progress and anchorage-independent growth. »
04/04/25

Caregiver smartphone data accounted for small variance in anxiety symptoms. »
04/04/25

CTC counts increased in AVPC and NEPC compared to metastatic hormone-sensitive prostate cancer. »
04/03/25